Not all cancer therapies are successful, but cancer researchers increasingly are able to identify the right treatments for the right patients at the right time. A researcher at the University of Oklahoma helped lead a study that made such a discovery, potentially resulting in thousands more cancer patients receiving the specific treatment that will help them the most.

Many people who were hospitalized with COVID-19 when the virus arrived in spring 2020 experienced a high rate of gastrointestinal problems and psychological trauma more than a year later, according to a recently published study led in Oklahoma by the University of Oklahoma College of Medicine.

When families receive counseling after a substance use disorder has wreaked havoc on parents and children alike, the desire for healing is often hampered by looming legal issues. To address both needs, the University of Oklahoma College of Medicine received a grant to launch an innovative medical-legal partnership.

The University of Oklahoma Health Sciences grew its funding from the National Institutes of Health to $64.4 million in 2022-23, an increase of more than $4 million over the previous year. That improves the campus’s ranking to 122 out of 2,886 institutions and other entities that receive NIH funding. The listing is compiled by the Blue Ridge Institute for Medical Research, which is regarded as the gold standard for ranking biomedical research institutions. Funding from the NIH is considered the key benchmark for research productivity and reputation for health sciences.

Leremy Colf, Ph.D., an associate professor in the Fran and Earl Ziegler College of Nursing at the University of Oklahoma Health Sciences, has been named a senior adviser to the newest agency in the federal government, the Advanced Research Projects Agency for Health, or ARPA-H. He will focus on health system resilience, a concept of critical importance as the world faces crises like climate change and emerging infectious diseases.